• Skip to main content
Scientific Sessions
Scientific Sessions Conference Coverage logo
  • Program
  • #ScientificSessions26
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 13th, 2020

GALACTIC-HF results

Investigator John Teerlink, MD, FAHA, summarizes the results of GALACTIC-HF.


Investigator John Teerlink, MD, FAHA, summarizes the results of GALACTIC-HF, which found that improving cardiac function with omecamtiv mecarbil significantly reduced the risk of a first heart failure event or cardiac death in patients with heart failure with reduced ejection fraction.
Interesting Stories
Prompt referral can be lifesaving
Sponsored by Edwards Lifesciences
Prompt referral can be lifesaving
Join us at the TRYNGOLZA® (olezarsen) Expert Theater at Scientific Sessions
Sponsored by Ionis Pharmaceuticals
Join us at the TRYNGOLZA® (olezarsen) Expert Theater at Scientific Sessions
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Sponsored by Novartis Pharmaceuticals Corporation
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Severe hypertriglyceridemia: see the data at Scientific Sessions, Booth #2802
Sponsored by Ionis Pharmaceuticals
Severe hypertriglyceridemia: see the data at Scientific Sessions, Booth #2802
Join our Novo symposium exploring GLP-1RAs in cardiovascular disease
Sponsored by Novo Nordisk Inc.
Join our Novo symposium exploring GLP-1RAs in cardiovascular disease
Latest research on thromboembolic disease targets
Sponsored by BMS/J&J Alliance
Latest research on thromboembolic disease targets
More Content
Large conference stage with vibrant red LED screens displaying Scientific Sessions branding and speaker presentations
Late-Breaking Science
Latest innovations designed to optimize arrhythmia care
Nov 13th, 2026
Professional speaker presenting at Scientific Sessions conference podium with branded display screens and data visualization charts
Late-Breaking Science
Potential changes in the cardiometabolic risk reduction landscape
Nov 13th, 2026
Professional speaker at Scientific Sessions conference presenting on stage with data visualization displayed on large red screens
Late-Breaking Science
Late-breaking trials showcase AI’s potential as a cardiovascular disease screening and diagnostic tool
Nov 13th, 2026
Scientific Sessions conference stage with red branding, large display screens, and audience seated in auditorium
Late-Breaking Science
Reports find multiple approaches improve outcomes after stroke
Nov 8th, 2026
Scientific Sessions conference stage with red branding, multiple screens displaying presentations, and audience seating
Late-Breaking Science
Late-breaking trials challenge conventional treatments to cardiovascular disease
Nov 8th, 2026
Large auditorium filled with attendees at a corporate conference or convention event with stage and screens
Late-Breaking Science
Lessons from landmark trials
Nov 7th, 2026
Large conference hall with attendees seated at tables facing a stage with American Heart Association presentation on red screen.
Home
#ScientificSessions26 Late-Breaking Science announced
Sep 25th, 2026
Scientific conference presentation with speaker at podium and research slide
Home
Approaches to ischemic heart disease before, during and after hospitalization
Nov 13th, 2025
Four professionals seated at conference, attentive and focused
Late-Breaking Science
Findings in heart failure late-breaking research
Nov 12th, 2025
Diverse group of professionals attentively listening at conference event
Home
Practice-changing trials in blood pressure control
Nov 12th, 2025
Professional working on laptop at desk with coffee mug, wearing blue blazer and glasses
Daily Coverage
Get Scientific Sessions OnDemand
Nov 12th, 2025
Diverse audience members seated at conference, bathed in warm red lighting
Daily Coverage
Cutting-edge valve and coronary trials
Nov 10th, 2025